133 related articles for article (PubMed ID: 9629821)
1. The short-term financial costs of abnormal Pap smears to women and government in Australia.
Kavanagh AM; Butler JR
Aust N Z J Public Health; 1998; 22(3 Suppl):347-52. PubMed ID: 9629821
[TBL] [Abstract][Full Text] [Related]
2. The price of guidelines: revising the national guidelines for managing Australian women with abnormal pap smears.
Mitchell H
Sex Health; 2006 Mar; 3(1):53-5. PubMed ID: 16607975
[TBL] [Abstract][Full Text] [Related]
3. The adequacy of management of women with CIN 2 and CIN 3 Pap smear abnormalities.
Towler BP; Irwig LM; Shelley JM
Med J Aust; 1993 Oct; 159(8):523, 526-8. PubMed ID: 8412951
[TBL] [Abstract][Full Text] [Related]
4. The management of women with initial minor Pap smear abnormalities.
Hunt JM; Irwig LM; Towler BP
Med J Aust; 1994 May; 160(9):558-63. PubMed ID: 8164554
[TBL] [Abstract][Full Text] [Related]
5. Should all women with cervical atypia be referred for colposcopy: a HARNET study. Harrisburgh Area Research Network.
Slawson DC; Bennett JH; Simon LJ; Herman JM
J Fam Pract; 1994 Apr; 38(4):387-92. PubMed ID: 8163964
[TBL] [Abstract][Full Text] [Related]
6. Resource use and cost analysis of managing abnormal Pap smears: a retrospective study in five countries.
Rash B; Martin-Hirsch P; Schneider A; Sideri M; Tan J; Torné A; Standaert B
Eur J Gynaecol Oncol; 2008; 29(3):225-32. PubMed ID: 18592784
[TBL] [Abstract][Full Text] [Related]
7. Reimbursed Costs of Management of Uterine Cervical Lesions in Poland--a Descriptive Analysis of Data from the National Health Fund and the Ministry of Health.
Nowakowski A; Śliwczyński A; Seroczyński P; Cybulski M; Teter Z
Cent Eur J Public Health; 2016 Jun; 24(2):163-8. PubMed ID: 27178030
[TBL] [Abstract][Full Text] [Related]
8. [Comparison between reference oncologic colpocytology and severity of intraepithelial cervical lesions].
Lapin GA; Derchain SF; Tambascia J
Rev Saude Publica; 2000 Apr; 34(2):120-5. PubMed ID: 10881146
[TBL] [Abstract][Full Text] [Related]
9. A cost-benefit analysis of colposcopy for cervical squamous intraepithelial lesions found on Papanicolaou smear.
Chesebro MJ; Everett WD
Arch Fam Med; 1996; 5(10):576-81. PubMed ID: 8930229
[TBL] [Abstract][Full Text] [Related]
10. Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing.
Paraskevaidis E; Malamou-Mitsi V; Koliopoulos G; Pappa L; Lolis E; Georgiou I; Agnantis NJ
Gynecol Oncol; 2001 Aug; 82(2):355-9. PubMed ID: 11531293
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
[TBL] [Abstract][Full Text] [Related]
12. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
[TBL] [Abstract][Full Text] [Related]
13. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
Martin-Hirsch P; Rash B; Martin A; Standaert B
BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
[TBL] [Abstract][Full Text] [Related]
14. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
[TBL] [Abstract][Full Text] [Related]
15. Impact of patient adherence and test performance on the cost-effectiveness of cervical cancer screening in developing countries: the case of Honduras.
Perkins RB; Langrish SM; Stern LJ; Burgess JF; Simon CJ
Womens Health Issues; 2010; 20(1):35-42. PubMed ID: 19944623
[TBL] [Abstract][Full Text] [Related]
16. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
[TBL] [Abstract][Full Text] [Related]
17. Colposcopy for cervical squamous intraepithelial lesions found on Papanicolaou smear.
Reed BD
Arch Fam Med; 1996; 5(10):582-4. PubMed ID: 8930230
[No Abstract] [Full Text] [Related]
18. Predicting nonattendance for colposcopy clinic follow-up after referral for an abnormal Pap smear.
Kavanagh AM; Simpson JM
Aust N Z J Public Health; 1996 Jun; 20(3):266-71. PubMed ID: 8768416
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities.
Andersson S; Dillner L; Elfgren K; Mints M; Persson M; Rylander E
Acta Obstet Gynecol Scand; 2005 Oct; 84(10):996-1000. PubMed ID: 16167918
[TBL] [Abstract][Full Text] [Related]
20. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
